Mimedx (MDXG) Free Cash Flow Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 31.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.61% |
| Dec 31, 2025 | 89.42% |
| Sep 30, 2025 | 262.83% |
| Jun 30, 2025 | 83.78% |
| Mar 31, 2025 | 35.28% |
| Dec 31, 2024 | 54.65% |
| Sep 30, 2024 | 47.41% |
| Jun 30, 2024 | 166.66% |
| Mar 31, 2024 | 36.81% |
| Dec 31, 2023 | 38.66% |
| Sep 30, 2023 | 66.36% |
| Jun 30, 2023 | 60.46% |
| Mar 31, 2023 | 29.38% |
| Dec 31, 2022 | 29.11% |
| Sep 30, 2022 | 29.74% |
| Jun 30, 2022 | -56.07% |
| Mar 31, 2022 | 13.37% |
| Dec 31, 2021 | -238.57% |
| Sep 30, 2021 | 62.49% |
| Jun 30, 2021 | -59.68% |
| Mar 31, 2021 | -47.56% |
| Dec 31, 2020 | -38.02% |
| Sep 30, 2020 | -33.46% |
| Jun 30, 2020 | -31.23% |
| Mar 31, 2020 | -48.13% |
| Dec 31, 2019 | -47.31% |
| Sep 30, 2019 | -65.74% |
| Jun 30, 2019 | -30.23% |
| Mar 31, 2019 | -74.67% |
| Dec 31, 2018 | -28.24% |
| Sep 30, 2018 | -37.96% |
| Jun 30, 2018 | 117.64% |
| Mar 31, 2018 | 35.40% |
| Dec 31, 2017 | 50.27% |
| Sep 30, 2017 | 16.12% |
| Jun 30, 2017 | 127.08% |
| Mar 31, 2017 | 103.78% |
| Dec 31, 2016 | 92.45% |
| Sep 30, 2016 | 18.87% |
| Jun 30, 2016 | 73.13% |
| Mar 31, 2016 | -11.19% |
| Dec 31, 2015 | 64.43% |
| Sep 30, 2015 | 95.78% |
| Jun 30, 2015 | 73.43% |
| Mar 31, 2015 | 61.64% |
| Dec 31, 2014 | 67.70% |
| Sep 30, 2014 | 125.25% |
| Jun 30, 2014 | 36.31% |
| Mar 31, 2014 | 4.72% |